Lymphocele after renal transplantation, a medical complication?

Journal of Nephrology

Volumn 24, Issue 6, 2011, Pages 707-716

  Minetti, Enrico E ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Graft rejection; Immunosuppressive agents; Kidney transplantation; Lymphocele

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID; CREATININE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OCTREOTIDE; PODOPLANIN ANTIBODY; POVIDONE IODINE; PREDNISONE; PROTEIN ANTIBODY; RAPAMYCIN; TACROLIMUS; TETRACYCLINE; TETRADECYL SULFATE SODIUM; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; AGE; BODY FLUID; CREATININE CLEARANCE; DEMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG ACTIVITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; FENESTRATION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; LYMPHATIC SYSTEM; LYMPHOCELE; LYMPHORRHAGIA; PATHOLOGICAL ANATOMY; PERCUTANEOUS DRAINAGE; PERINEPHRIC FLUID; POSTOPERATIVE COMPLICATION; REVIEW; RISK FACTOR; SYMPTOMATOLOGY;

HUMANS; INCIDENCE; KIDNEY; KIDNEY TRANSPLANTATION; LYMPH; LYMPHOCELE; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 80955149553     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000004     Document Type: Review

References (90)

1. Pollak R, Veremis SA, Maddux MS, Mozes MF. The natural history of and therapy for perirenal fluid collections following renal transplantation. J Urol. 1988;140:716-720.
2. Ulrich F, Niedzwiecki S, Fikatas P, et al. Symptomatic lymphoceles after kidney transplantation: multivariate analysis of risk factors and outcome after laparoscopic fenestration. Clin Transplant. 2010;24:273-280.
3. Lange V, Schardey HM, Meyer G, Illner WD, Petersen P, Land W. Laparoscopic deroofing of post-transplant lymphoceles. Transpl Int. 1994;7:140-143.
4. Saidi RF, Wertheim JA, Ko DS, et al. Impact of donor kidney recovery method on lymphatic complications in kidney transplantation. Transplant Proc. 2008;40:1054-1055.
5. Veeramani M, Mishra S, Kurien A, Ganpule A, Sabnis R, Desai M. Does rejection have a role in lymphocele formation post renal transplantation? A single centre experience. In dian J Urol. 2010;26:193-195.
6. Røine E, Bjørk IT, Oyen O. Targeting risk factors for impaired wound healing and wound complications after kidney transplantation. Transplant Proc. 2010;42:2542-2546.
7. Zaontz MR, Firlit CF. Pelvic lymphocele after pediatric renal transplantation: a successful technique for prevention. J Urol. 1988;139:557-559.
8. Auckland K, Bogusky RT, Renkin EM. Renal cortical interstitium and fluid absorption in peritubular capillaries. Am J Physiol. 1994;266:175-184.
9. Ishikawa Y, Akasaka Y, Kiguchi H, et al. The human renal lymphatics under normal and pathological conditions. Histopathology. 2006;49:265-273.
10. McIntosh GH, Morris B. The lymphatics of the kidney and the formation of renal lymph. J Physiol. 1971;214:365-376.
11. Holmes MJ, O'Morchoe PJ, O'Morchoe CCC. Morphology of the intrarenal lymphatic system: capsular and hilar communications. Am J Anat. 1977;149:333-351.
12. Aukland K. Arnold Heller and the lymph pump. Acta Physiol Scand. 2005;185:171-180.
13. McHale NG, Thornbury K. A method for studying lymphatic pumping activity in conscious and anaesthetized sheep. J Physiol. 1986;378:109-118.
14. Rohn DA, Stewart RH, Elk JR, Laine GA, Drake RE. Renal lymphatic function following venous pressure elevation. Lymphology. 1996;29:67-75.
15. Koene RA, Skotnicki SH, Debruyne FM. Spontaneous renal decapsulation with excessive fluid leakage after transplantation. N Engl J Med. 1979;300:1030-1031.
16. Keyl MJ, Scott JB, Dabney JM, et al. Composition of canine renal hilar lymph. Am J Physiol. 1965;209:1031-1033.
17. Pacovsky J, Hyspler R, Navratil P, Ticha A, Brodak M. The estimation of post-transplant lymphocele origin using creatine kinase activity. Ups J Med Sci. 2010;115:187-192.
18. Bull GM, Metaxas P. The theory and application or clearance methods for determining renal blood and lymph flow. Clin Sci. 1962;23:515-523.
19. O'Morchoe CCC, O'Morchoe PJ. Renal contribution to thoracic duct lymph in dogs. J Physiol. 1968;194:305-315.
20. Castillo CE, Lillioja S. Peripheral lymphatic cannulation for physiological analysis of interstitial fluid compartment in humans. Am J Physiol. 1991;261:1324-1328.
21. Braun WE, Banowsky LH, Straffon RA, et al. Lymphocytes associated with renal transplantation. Report of 15 cases and review of the literature. Am J Med. 1974;57:714-729.
22. Howard RJ, Simmons RL, Najarian JS. Prevention of lymphoceles following renal transplantation. Ann Surg. 1976;184:166-168.
23. Kim JK, Jeong YY, Kim YH, Kim YC, Kang HK, Choi HS. Postoperative pelvic lymphocele: treatment with simple percutaneous catheter drainage. Radiology. 1999;212:390-394.
24. Sogani PC, Watson RC, Whitmore WF Jr. Lymphocele after pelvic lymphadenectomy for urologic cancer. Urology. 1981;17:39-43.
25. Pepper RJ, Pati J, Kaisary AV. The incidence and treatment of lymphoceles after radical retropubic prostatectomy. BJU Int. 2005;95:772-775.
26. Sansalone CV, Aseni P, Minetti E, et al. Is lymphocele in renal transplantation an avoidable complication? Am J Surg. 2000;179:182-185.
27. Griffiths AB, Fletcher EW, Morris PJ. Lymphocele after renal transplantation. Aust N Z J Surg. 1979;49:626-628.
28. Yap R, Madrazo B, Oh HK, Dienst SG. Perirenal fluid collection after renal transplant. Am Surg. 1981;47:287-290.
29. Burgos FJ, Teruel JL, Mayayo T, et al. Diagnosis and management of lymphoceles after renal transplantation. Br J Urol. 1988;61:289-293.
30. Khauli RB, Stoff JS, Lovewell T, Ghavamian R, Baker S. Posttransplant lymphoceles: a critical look into the risk factors, pathophysiology and management. J Urol. 1993;150:22-26.
31. Bischof G, Rockenschaub S, Berlakovich G, et al. Management of lymphoceles after kidney transplantation. Transpl Int. 1998;11:277-280.
32. Lipay MA, Noronha IL, Vidonho Júnior A, Romão Júnior JE, Campagnari JC, Srougi M. Lymphocele: a possible relationship with acute cellular rejection in kidney transplantation. Sao Paulo Med J. 1999;117:238-242.
33. Øyen O, Siwach V, Line PD, et al. Improvement of post-transplant lymphocele treatment in the laparoscopic era. Transpl Int. 2002;15:406-410.
34. Goel M, Flechner SM, Zhou L, et al. The influence of various maintenance immunosuppressive drugs on lymphocele formation and treatment after kidney transplantation. J Urol. 2004;171:1788-1792.
35. Atray NK, Moore F, Zaman F, et al. Post transplant lymphocele: a single centre experience. Clin Transplant. 2004;18(Suppl 12):46-49.
36. Risaliti A, Sainz-Barriga M, Baccarani U, et al. Surgical complications after kidney transplantation. G Ital Nefrol. 2004;21(Suppl 26):S43-S47.
37. Tasar M, Gulec B, Saglam M, Yavuz I, Bozlar U, Ugurel S. Posttransplant symptomatic lymphocele treatment with percutaneous drainage and ethanol sclerosis: long-term followup. Clin Imaging. 2005;29:109-116.
38. Dubeaux VT, Oliveira RM, Moura VJ, Pereira JM, Henriques FP. Assessment of lymphocele incidence following 450 renal transplantations. Int Braz J Urol. 2004;30:18-21.
39. Hamza A, Fischer K, Koch E, et al. Diagnostics and therapy of lymphoceles after kidney transplantation. Transplant Proc. 2006;38:701-706.
40. Shum CF, Lau KO, Sy JL, Cheng WS. Urological complications in renal transplantation. Singapore Med J. 2006;47:388-391.
41. Zietek Z, Sulikowski T, Tejchman K, et al. Lymphocele after kidney transplantation. Transplant Proc. 2007;39:2744-2747.
42. Krol IR, Kolonko A, Chudek J, et al. Did volume of lymphocele after kidney transplantation determine the choice of treatment modality? Transplant Proc. 2007;39:2740-2743.
43. Derouiche A, Mechri M, Ktari MM, Helal I, Ben Abdallah T, Chebil M. Facteurs de risque de la lymphocèle post-greffe rénale. Prog Urol. 2010;20:301-306.
44. Vester U, Kranz B, Testa G, Paul A, Broelsch CE, Hoyer PF. Medical and surgical aspects of pediatric renal transplantation using living donors. Transplant Proc. 2004;36: 1308-1310.
45. Shokeir AA, el-Diasty TA, Ghoneim MA. Percutaneous treatment of lymphocele in renal transplant recipients. J Endourol. 1993;7:481-485.
46. Zargar-Shoshtari MA, Soleimani M, Salimi H, Mehravaran K. Symptomatic lymphocele after kidney transplantation: a single-center experience. Urol J. 2008;5:34-36.
47. Matas AJ, Payne WD, Sutherland DE, et al. 2,500 living donor kidney transplants: a single-center experience. Ann Surg. 2001;234:149-164.
48. Hong LQ, Xu QF, Huang ZY. Diagnosis and treatment of lymphorrhagia or lymphocele after kidney transplantation. J Sun Yat-Sen University (Medical Sciences). 2007;04-002.
49. Lundin C, Bersztel A, Wahlberg J, Wadström J. Low molecular weight heparin prophylaxis increases the incidence of lymphocele after kidney transplantation. Ups J Med Sci. 2002;107:9-15.
50. Mazzucchi E, Souza AA, Nahas WC, Antonopoulos IM, Piovesan AC, Arap S. Surgical complications after renal transplantation in grafts with multiple arteries. Int Braz J Urol. 2005;31:125-130.
51. Mokos I, Basic-Jukic N, Kastelan Z, Kes P, Pasini J. Influence of long-term dialysis treatment on operative complications after renal transplantation. Transplant Proc. 2010;42:2531-2533.
52. Grim SA, Slover CM, Sankary H, Oberholzer J, Benedetti E, Clark NM. Risk factors for wound healing complications in sirolimus-treated renal transplant recipients. Transplant Proc. 2006;38:3520-3523.
53. Capocasale E, Busi N, Valle RD, et al. Octreotide in the treatment of lymphorrhea after renal transplantation: a preliminary experience. Transplant Proc. 2006;38:1047-1048.
54. Brown ED, Chen MYM, Wolfman NT, Ott DJ, Watson NE Jr. Complications of renal transplantation: evaluation with US and radionuclide imaging. Radiographics. 2000;20:607-622.
55. Smyth GP, Beitz G, Eng MP, Gibbons N, Hickey DP, Little DM. Long-term outcome of cadaveric renal transplant after treatment of symptomatic lymphocele. J Urol. 2006;176: 1069-1072.
56. Pedersen NC, Morris B. The role of the lymphatic system in the rejection of homografts: a study of lymph from renal transplants. J Exp Med. 1970;131:936-969.
57. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int. 1993;44:411-422.
58. Rush D, Nickerson P, Gough J, et al. Beneficial effects of treatment of early subclinical rejection: a randomized study. J Am Soc Nephrol. 1998;9:2129-2134.
59. Langer RM, Kahan BD. Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients. Transplantation. 2002;77:804-808.
60. Ekberg H, Grinyó J, Nashan B, et al. Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study. Am J Transplant. 2007;7:560-570.
61. Ekberg H, Tedesco-Silva H, Demirbas A, et al; ELITE-Symphony Study. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med. 2007;357:2562-2575.
62. Eliska O, Elisková M, Mirejovský P. Lymph vessels of the transplanted kidney. Nephron. 1986;44:136-141.
63. Bruyère F, Noël A. Lymphangiogenesis: in vitro and in vivo models. FASEB J. 2010;24:8-21.
64. Lopau K, Syamken K, Rubenwolf P, Riedmiller H, Wanner C. Impact of mycophenolate mofetil on wound complications and lymphoceles after kidney transplantation. Kidney Blood Press Res. 2010;33:52-59.
65. Kerjaschki D. How to control lymphangiogenesis: a novel role for rapamycin. Kidney Int. 2007;71:717-719.
66. Ekberg H, Bernasconi C, Nöldeke J, et al. Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study. Nephrol Dial Transplant. 2010;25:2004-2010.
67. Büchler M, Caillard S, Barbier S, et al; SPIESSER Group. Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids. Am J Transplant. 2007;7:2522-2531.
68. Campistol JM, Cockwell P, Diekmann F, et al. Practical recommendations for the early use of m-TOR inhibitors (sirolimus) in renal transplantation. Transpl Int. 2009;22:681-687.
69. Valente JF, Hricik D, Weigel K, et al. Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation. Am J Transplant. 2003;3:1128-1134.
70. Rogersa CC, Hanawaya M, Allowayb RR, et al. Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy. Transplant Proc. 2005;37:795-797.
71. Castro G, Freitas C, Beirão I, Rocha G, Henriques AC, Cabrita A. Chylous ascites in a renal transplant recipient under sirolimus (rapamycin) treatment. Transplant Proc. 2008;40:1756-1758.
72. Lebranchu Y, Thierry A, Toupance O, et al. Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study. Am J Transplant. 2009;9:1115-1123.
73. Derweesh IH, Ismail HR, Goldfarb DA, et al. Intraoperative placing of drains decreases the incidence of lymphocele and deep vein thrombosis after renal transplantation. BJU Int. 2008;101:1415-1419.
74. Sandrini S, Setti G, Bossini N, et al. Steroid withdrawal five days after renal transplantation allows for the prevention of wound-healing complications associated with sirolimus therapy. Clin Transplant. 2009;23:16-22.
75. Stallone G, Infante B, Grandaliano G, et al. Management of side effects of sirolimus therapy. Transplantation. 2009;27;87:S23-S26.
76. Zagdoun E, Ficheux M, Lobbedez T, et al. Complicated lymphoceles after kidney Transplantation. Transplant Proc. 2010;42:4322-4325.
77. Tondolo V, Citterio F, Massa A, et al. Lymphocele after renal transplantation: the influence of the immunosuppressive therapy. Transplant Proc. 2006;38:1051-1052.
78. Srivastava A, Muruganandham K, Vinodh PB, et al. Postrenal transplant surgical complications with newer immunosuppressive drugs: mycophenolate mofetil vs. m-TOR inhibitors. Int Urol Nephrol. 2010;42:279-284.
79. Mason HS, Resnick D, Benedetti E. Laparoscopic drainage of giant lymphocele after renal transplantation. J Laparoendosc Adv Surg Tech A. 1999;9:165-169.
80. DeCamp MM, Tilney NL. Late development of intractable lymphocele after renal transplantation. Transplant Proc. 1988;20:105-109.
81. Thompson TJ, Neale TJ. Acute perirenal lymphocele formation8 years after renal transplantation. Aust N Z J Surg. 1989;59:583-585.
82. Sollinger HW, Starling JR, Oberley T, Glass NR, Belzer FO. Severe "weeping" kidney disease after transplantation: a case report. Transplant Proc. 1983;15:2157-2160.
83. Myhre HA, Oyen O, Karbo O, et al. Successful treatment of spontaneous kidney graft decapsulation 18 years after renal transplantation: a case report. NDT Plus. 2010;3:100-102.
84. Guttmann RD. Renal transplantation (second of two parts). N Engl J Med. 1979;301:1038-1048.
85. Fjeldborg O, Kim CH. Spontaneous rupture of renal transplant. Scand J Urol Nephrol. 1974;8:31-36.
86. Homan WP, Cheigh JS, Kim SJ, et al. Renal allograft fracture: clinicopathological study of 21 cases. Ann Surg. 1977;186:700-703.
87. Yang MH, Loong CC, Wu CW, Lui WY. Late spontaneous kidney graft decapsulation after administration of sirolimus in a recipient with chronic hepatitis B and C infection: a case report. Transplant Proc. 2008;40:2437-2439.
88. Stallone G, Infante B, Gesualdo L. Older donors and older recipients in kidney transplantation. J Nephrol. 2010;23(Suppl 15):S98-S103.
89. Remuzzi G, Cravedi P, Perna A, et al; Dual Kidney Transplant Group. Long-term outcome of renal transplantation from older donors. N Engl J Med. 2006;354:343-352.
90. Ekser B, Furian L, Broggiato A, et al. Technical aspects of unilateral dual kidney transplantation from expanded criteria donors: experience of 100 patients. Am J Transplant. 2010;10:2000-2007.